ArticleEuropean journal of nutrition2026
Protective effect of extra virgin olive oil (EVOO) consumption on the physical component of health-related quality of life in aging adults.
Article in European journal of nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesThe Mediterranean dietary pattern (MedDiet) is associated with numerous health benefits, particularly in preventing chronic diseases and promoting well-being. Extra virgin olive oil (EVOO), a key component of the MedDiet, is rich in monounsaturated fatty acids (MUFAs), polyphenols, and antioxidants, which may help slow age-related physical decline. Health-related quality of life (HRQoL) is a crucial indicator of population health, and with an aging population, it is essential to assess whether dietary habits influence the physical component (Comp-P) of HRQoL. This study examines this association in older adults to provide evidence supporting dietary recommendations for healthy aging.
methodsA cross-sectional study was conducted on 180 physically active adults aged 41–80, all adhering to the MedDiet. Data were collected using the MEDAS, RAPA-Q, and SF-36 questionnaires. Participants were classified into two groups based on EVOO consumption: MT4 (≥ 4 tablespoons/day) and LT4 (< 4 tablespoons/day).
resultsIn the LT4 group, Comp-P and age showed a moderate, negative, and significant correlation (r = − 0.349, p = 0.009), while in the MT4 group, the correlation was weak, negative, and not significant (r = − 0.007, p = 0.431). Similarly, bodily pain correlated negatively with age in the LT4 group (r = − 0.328, p = 0.014), whereas no significant association was found in the MT4 group (r = 0.102, p = 0.234).
conclusionsAmong adults aged 41–80, higher EVOO consumption (≥ 4 tablespoons/day) may have a protective effect, mitigating the impact of aging on self-perceived physical health and functional capacity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.